Phosphorescent Platinum(II) Complexes with a Spiro-fused Xanthene Unit: Synthesis and Photophysical Properties

Novel platinum(II) complexes, derived from the spiro[fluorene-9,9'-xanthene] (SFX) motif, were synthesized and combined with different auxiliary ligands such as acetylacetonate (acac), bis(2,4,6-trimethylphenyl)propane-1,3-dionate (mesacac) and dihydrobis(3,5-dimethylpyrazole-1-yl) borate. The final products were obtained in yields of up to 36 % and characterized by NMR, X-ray and combustion analysis. These complexes have structured green-blue emission spectra with Commission Internationale de l'Éclairage (CIExy) coordinates of (0.21;0.46). Excellent photoluminescence quantum yields (PLQYs) ranging from 87 %-91 % were found. The emission lifetimes vary from 33 μs to 43 μs. Calculations on the B3LYP/6-311++G** level of theory reveal, that the nature of the emissive state is dependent on the positional regioisomerism of the SFX motif. The 2-SFX complexes demonstrate ligand-centered (3LC) emission, while the 2'-SFX regioisomer with the mesacac ligand shows a strong 3MLCT character.

Cyclometalated Spirobifluorene Imidazolylidene Platinum(II) Complexes with Predominant 3LC Emissive Character and High Photoluminescence Quantum Yields

Two novel bidentate C^C*_spiro cyclometalated platinum(II) complexes comprising a spiro-conjugated bifluorene ligand and different β-diketonate auxiliary ligands are synthesized and characterized. Their preparation employs a robust and elaborate synthetic protocol commencing with an N-heterocyclic carbene precursor. Structural characterization by means of NMR techniques and solid-state structures validate the proposed and herein presented molecular scaffolds. Photophysical studies, including laser flash photolysis methods, reveal an almost exclusively ligand-centered triplet state, governed by the C^C*_spiro-NHC ligand. The high triplet energies and the long triplet lifetimes in the order of 30 μs in solution make the complexes good candidates for light-emitting diode-driven photocatalysis, as initial energy transfer experiments reveal. In-depth time-dependent density functional theory investigations are in excellent accordance with our spectroscopic findings. The title compounds are highly emissive in the bluish-green color region with quantum yields of up to 87% in solid-state measurements.

P2O5-Promoted Cyclization of Di[aryl(hetaryl)methyl] Malonic Acids as a Pathway to Fused Spiro[4.4]nonane-1,6-Diones

Conventional spiro-linked conjugated materials are attractive for organic optoelectronic applications due to the unique combination of their optical and electronic properties. However, spiro-linked conjugated materials with conjugation extension directed along the main axis of the molecule are still only rare examples among the vast number of spiro-linked conjugated materials. Herein, the synthesis, leading to π-extended spiro-linked conjugated materials─spiro[4.4]nonane-1,6-diones and spiro[5.5]undecane-1,7-diones─has been developed and optimized. The proposed design concept starts from readily available malonic esters and contains several steps: double alkylation of malonic ester with bromomethylaryl(hetaryl)s; conversion of a malonic ester into the corresponding malonic acid; electrophilic spirocyclization of the latter into the annulated spiro[4.4]nonane-1,6-dione or spiro[5.5]undecane-1,7-dione in the presence of phosphorus pentoxide. On the basis of these insights, the developed method yielded spiro-linked conjugated cores fused with benzene, thiophene, and naphthalene, decorated with active halogen atoms. The structures of the synthesized spirocycles were determined by single-crystal X-ray diffraction analysis. Benzene fused spiro[4.4]nonane-1,6-dione decorated with bromine atoms was transformed into V-shape phenylene-thiophene co-oligomer type spirodimers via Stille coupling. The spiro-bis(4-n-dodecylphenyl)-2,2'-bithiophene derivative possessed high photoluminescence properties in both solution and solid state with a photoluminescence quantum yield (PL QY) of 38%.

Boron-containing nucleosides as tools for boron-neutron capture therapy

Despite the significant progress in cancer cure, the development of new approaches to cancer therapy is still of great importance since many deadly tumors remain untreatable. Boron neutron capture therapy (BNCT), proposed more than eighty years ago, is still considered a potentially advantageous approach. Irradiation of cells containing ¹⁰B isotopes with epithermal neutrons and the consequent decay of boron nuclei releases particles that deposit high energy along a very short path, inflicting heavy damage on the target cells but sparing the neighbouring tissue. Delivery and preferential accumulation of boron in cancer cells are the major obstacles that slow down the clinical use of BNCT. Since DNA damage caused by irradiation is the major reason for cell death, the incorporation of boron-containing nucleotides into the DNA of cancer cells may significantly increase the efficacy of BNCT. In this review, we discuss the current state of knowledge in the synthesis of boron-containing nucleosides and their application for BNCT with a special focus on their possible incorporation into genomic DNA.